CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
23,812,013
Share change
+518,546
Total reported value
$25,000,000
Price per share
$1.05
Number of holders
51
Value change
+$512,936
Number of buys
17
Number of sells
17

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Broadfin Capital, LLC
13F
Company
6.7%
8,200,000
$8,938,000 30 Sep 2016
13F
BAKER BROS. ADVISORS LP
13F
Company
4.1%
5,102,153
$5,561,000 30 Sep 2016
13F
VANGUARD GROUP INC
13F
Company
2.4%
2,909,584
$3,172,000 30 Sep 2016
13F
Point72 Asset Management, L.P.
13F
Company
1.9%
2,366,964
$2,580,000 30 Sep 2016
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.6%
745,077
$812,000 30 Sep 2016
13F
TANAKA CAPITAL MANAGEMENT INC
13F
Company
0.53%
653,352
$712,000 30 Sep 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.39%
478,164
$521,000 30 Sep 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.38%
469,440
$512,000 30 Sep 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.37%
460,267
$501,000 30 Sep 2016
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.2%
243,236
$265,000 30 Sep 2016
13F
ROYAL BANK OF CANADA
13F
Company
0.19%
236,061
$257,000 30 Sep 2016
13F
CORRADO ADVISORS, LLC
13F
Company
0.15%
181,900
$198,000 30 Sep 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.15%
179,976
$196,000 30 Sep 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.14%
173,400
$189,000 30 Sep 2016
13F
CREDIT SUISSE AG/
13F
Company
0.12%
143,851
$157,000 30 Sep 2016
13F
NORTHERN TRUST CORP
13F
Company
0.1%
127,146
$139,000 30 Sep 2016
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.07%
80,497
$88,000 30 Sep 2016
13F
Bank of New York Mellon Corp
13F
Company
0.06%
71,037
$77,000 30 Sep 2016
13F
Weiss Multi-Strategy Advisers LLC
13F
Company
0.06%
68,000
$74,000 30 Sep 2016
13F
BlackRock Fund Advisors
13F
Company
0.04%
45,385
$49,000 30 Sep 2016
13F
STATE STREET CORP
13F
Company
0.04%
45,300
$49,000 30 Sep 2016
13F
AGRAN LIBBIE
13F
Company
0.04%
44,000
$48,000 30 Sep 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
41,332
$45,000 30 Sep 2016
13F
THOMPSON DAVIS & CO., INC.
13F
Company
0.02%
24,920
$27,000 30 Sep 2016
13F
Commonwealth Equity Services, Inc
13F
Company
0.02%
24,000
$26,000 30 Sep 2016
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.02%
21,335
$23,000 30 Sep 2016
13F
HBK Sorce Advisory LLC
13F
Company
0.02%
21,109
$23,000 30 Sep 2016
13F
ProVise Management Group, LLC
13F
Company
0.02%
19,000
$21,000 30 Sep 2016
13F
COMPTON CAPITAL MANAGEMENT INC /RI
13F
Company
0.02%
20,000
$18,000 30 Sep 2016
13F
New England Private Wealth Advisors LLC
13F
Company
0.01%
15,554
$17,000 30 Sep 2016
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.01%
15,500
$17,000 30 Sep 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
15,000
$16,000 30 Sep 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.01%
15,000
$16,000 30 Sep 2016
13F
Creative Planning
13F
Company
0.01%
10,681
$12,000 30 Sep 2016
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
7,710
$8,000 30 Sep 2016
13F
Cutler Group LLC / CA
13F
Company
0%
5,646
$6,000 30 Sep 2016
13F
CITIGROUP INC
13F
Company
0%
4,088
$4,000 30 Sep 2016
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
3,218
$4,000 30 Sep 2016
13F
Vantage Investment Advisors, LLC
13F
Company
0%
3,000
$3,000 30 Sep 2016
13F
MSI Financial Services Inc
13F
Company
0%
2,800
$3,000 30 Sep 2016
13F
Geneos Wealth Management Inc.
13F
Company
0%
2,500
$2,000 30 Sep 2016
13F
Walleye Trading LLC
13F
Company
0%
2,200
$2,000 30 Sep 2016
13F
MORGAN STANLEY
13F
Company
0%
2,084
$2,000 30 Sep 2016
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
2,000
$2,000 30 Sep 2016
13F
ADVANTAGE INVESTMENT MANAGEMENT, LLC
13F
Company
0%
1,500
$2,000 30 Sep 2016
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,459
$2,000 30 Sep 2016
13F
BANK OF MONTREAL /CAN/
13F
Company
0%
1,000
$1,000 30 Sep 2016
13F
IFP Advisors, Inc
13F
Company
0%
1,000
$1,000 30 Sep 2016
13F
CWM, LLC
13F
Company
0%
500
$1,000 30 Sep 2016
13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q4 2016

As of 31 Dec 2016, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,812,013 shares. The largest 10 holders included Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Point72 Asset Management, L.P., venBio Select Advisor LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., TANAKA CAPITAL MANAGEMENT INC, BlackRock Institutional Trust Company, N.A., GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders
46
Q4 2016 holders
51
Holder diff
5
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 Value $ Q4 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.